Zentalis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZNTL and other ETFs, options, and stocks.About ZNTL
Zentalis Pharmaceuticals, Inc. is a clinical oncology innovator developing an oral, non-chemotherapy, biomarker-driven treatment approach for ovarian cancer and multiple tumor types. The therapeutics development and biomarker expertise is advancing monotherapy and combination studies of its investigational potential first-in-class WEE1 inhibitor, azenosertib.
ZNTL Key Statistics
Stock Snapshot
As of today, Zentalis Pharmaceuticals(ZNTL) shares are valued at $3.58. The company's market cap stands at 255.2M, with a P/E ratio of -2.06.
On 2026-06-10, Zentalis Pharmaceuticals(ZNTL) stock traded between a low of $3.49 and a high of $3.77. Shares are currently priced at $3.58, which is +2.6% above the low and -5.0% below the high.
Zentalis Pharmaceuticals(ZNTL) shares are trading with a volume of 442.9K, against a daily average of 755.86K.
In the last year, Zentalis Pharmaceuticals(ZNTL) shares hit a 52-week high of $6.95 and a 52-week low of $1.13.
In the last year, Zentalis Pharmaceuticals(ZNTL) shares hit a 52-week high of $6.95 and a 52-week low of $1.13.
Analyst ratings
56%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.